Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chattem Considering OTC Cough/Cold, GI Tract Purchases, Exec Says

This article was originally published in The Tan Sheet

Executive Summary

Chattem is eyeing the OTC cough/cold and gastrointestinal tract categories as possible areas for expansion through acquisition, President & Chief Operating Officer Alec Taylor said at a BB&T Capital Markets Equity Research Conference in Leesburg, Va. May 21

You may also be interested in...



J&J Adds Cortaid, Insight Gets Bonine In Pfizer/Pharmacia Pre-Merger Sell Off

Johnson & Johnson will add Pharmacia's Cortaid OTC anti-itch and rash line to its skin remedies business in one of several divestitures planned to resolve Federal Trade Commission concerns regarding potential monopolies resulting from the merger of Pharmacia and Pfizer

Chattem Selsun Blue Purchase Provides Entry Into Five New Foreign Markets

Line extensions and a major marketing push are among the growth tactics Chattem expects to pursue when it brings Selsun Blue into its consumer health portfolio. Chattem has agreed to purchase the anti-dandruff line from Abbott Labs subsidiary Ross Products

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS095492

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel